Jim Simons Cue Biopharma, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CUE
# of Institutions
52Shares Held
14.9MCall Options Held
10.1KPut Options Held
1.4K-
Bleichroeder LP New York, NY5MShares$4.15 Million1.56% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.77 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.32MShares$1.92 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$628,0900.0% of portfolio
-
Geode Capital Management, LLC Boston, MA694KShares$575,9280.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $29.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...